STUDYING THE ROLE OF MACROPHAGES IN CIRCULATING PROSTATE CANCER CELLS BY IN VIVO FLOW CYTOMETRY

Metastasis is a very complicated multi-step process and accounts for the low survival rate of the cancerous patients. To metastasize, the malignant cells must detach from the primary tumor and migrate to secondary sites in the body through either blood or lymph circulation. Macrophages appear to be directly involved in tumor progression and metastasis. However, the role of macrophages in affecting cancer metastasis has not been fully elucidated. Here, we have utilized an emerging technique, namely in vivo flow cytometry (IVFC) to study the depletion kinetics of circulating prostate cancer cells in mice and determine how depletion of macrophages by the liposome-encapsulated clodronate affects the depletion kinetics. Our results show different depletion kinetics of PC-3 cells between the macrophage-deficient group and the control group. The number of circulating tumor cells (CTCs) in the macrophage-deficient group decreases in a slower manner compared to the control mice group. The differences in depletion kinetics indicate that the absence of macrophages facilitates the stay of prostate cancer cells in circulation. In addition, our imaging data suggest that macrophages might be able to arrest, phagocytose and digest PC-3 cells. Therefore, phagocytosis may mainly contribute to the depletion kinetic differences. The developed methods elaborated here would be useful to study the relationship between macrophages and tumor metastasis in small animal cancer models.

[1]  S. Huh,et al.  Tumor and Stem Cell Biology Cancer Research Transiently Entrapped Circulating Tumor Cells Interact with Neutrophils to Facilitate Lung Metastasis Development , 2010 .

[2]  Jeremy J. W. Chen,et al.  Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  A. Chokkalingam,et al.  Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.

[4]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[5]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[6]  P. Marrack,et al.  Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. , 2003, Blood.

[7]  G. Meijer,et al.  Macrophages direct tumour histology and clinical outcome in a colon cancer model , 2005, The Journal of pathology.

[8]  T. K. van den Berg,et al.  Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.

[9]  J. J. Visser,et al.  Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells , 1993, Cancer Immunology, Immunotherapy.

[10]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[11]  S. Meijer,et al.  Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver , 1996, Hepatology.

[12]  N. Rooijen,et al.  Macrophage Subset Repopulation in the Spleen: Differential Kinetics After Liposome‐Mediated Elimination , 1989, Journal of leukocyte biology.

[13]  N. Van Rooijen,et al.  Transient suppression of macrophage functions by liposome-encapsulated drugs. , 1997, Trends in biotechnology.

[14]  Tayyaba Hasan,et al.  Flow Cytometry : A New Method for Enumerating Circulating Cancer Cells , 2004 .

[15]  R. Norman,et al.  Intrabursal Injection of Clodronate Liposomes Causes Macrophage Depletion and Inhibits Ovulation in the Mouse Ovary1 , 2000, Biology of reproduction.

[16]  Philip S Low,et al.  In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.

[17]  E. Ruoslahti.  How cancer spreads. , 1996, Scientific American.

[18]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[19]  Charles P. Lin,et al.  In vivo flow cytometer for real-time detection and quantification of circulating cells. , 2004, Optics letters.

[20]  R. Zinkernagel,et al.  Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection , 1997, European journal of immunology.

[21]  P. Stattin,et al.  Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. , 2000, International journal of oncology.

[22]  Xunbin Wei,et al.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.

[23]  A. Sica,et al.  Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.

[24]  N. Kajiwara,et al.  CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection , 2005, Nature Medicine.

[25]  Wei-Zhong Wu,et al.  Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis. , 2012, Cancer research.

[26]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.